stockrow
Monday 9 November 2026
Export SION’s income statement to Excel — free account
Sionna Therapeutics, Inc.
SION- EPS
- −61.0%
- Free cash flow
- −22.4%
Quarter to June 2026, against a year earlier
3.28
0.00
0.00%
Follow SION
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+7 more quarters Free account |
25.61 | 20.61 | 22.60 | 20.05 |
Net Debt/EBITDA |
10.16 | 9.91 | 7.29 | 6.50 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.75 | 0.81 | 0.82 | 0.74 | |
Capex/Depreciation |
0.13 | 1.01 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.35) | (0.42) | (0.49) | (0.49) | |
Cash per Share |
5.61 | 5.90 | 4.81 | 4.67 | |
Shareholders Equity per Share |
7.27 | 7.68 | 6.42 | 5.89 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.27 | 7.68 | 6.42 | 5.89 | |
Free Cash Flow |
(15.32) | (16.83) | (21.84) | (22.22) | |
Working Capital |
242.48 | 229.71 | 211.18 | 205.35 | |
Capital Expenditures |
(0.09) | (0.20) | — | — | |
Net Current Asset Value |
234.73 | 222.30 | 204.13 | 198.66 | |
| Other line items | |||||
Quick Ratio |
25.21 | 20.14 | 22.11 | 19.57 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.34) | (0.42) | (0.49) | (0.49) | |
Capex per Share |
0.00 | (0.01) | 0.00 | 0.00 | |
Average Payables |
1.10 | 0.98 | 3.56 | 0.72 | |
Average Assets |
195.61 | 255.85 | 337.36 | 317.65 | |
Average Common Equity |
103.39 | 71.56 | 319.99 | 301.10 | |
Capex to Sales |
0.00 | 0.00 | — | — |
Columns are period end dates